Research ArticleTheranostics
18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Matthias Eiber, Markus Kroenke, Alexander Wurzer, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Kilian Schiller, Thomas Langbein, Gabriel Buschner, Hans-Jürgen Wester and Wolfgang Weber
Journal of Nuclear Medicine May 2020, 61 (5) 696-701; DOI: https://doi.org/10.2967/jnumed.119.234914
Matthias Eiber
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Markus Kroenke
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Alexander Wurzer
2Chair of Radiopharmacy, Technical University of Munich, Munich, Germany
Lena Ulbrich
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Lena Jooß
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Tobias Maurer
3Department of Urology and Martini-Klinik, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Thomas Horn
4Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; and
Kilian Schiller
5Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Thomas Langbein
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Gabriel Buschner
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Hans-Jürgen Wester
2Chair of Radiopharmacy, Technical University of Munich, Munich, Germany
Wolfgang Weber
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 5
May 1, 2020
18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Matthias Eiber, Markus Kroenke, Alexander Wurzer, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Kilian Schiller, Thomas Langbein, Gabriel Buschner, Hans-Jürgen Wester, Wolfgang Weber
Journal of Nuclear Medicine May 2020, 61 (5) 696-701; DOI: 10.2967/jnumed.119.234914
18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Matthias Eiber, Markus Kroenke, Alexander Wurzer, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Kilian Schiller, Thomas Langbein, Gabriel Buschner, Hans-Jürgen Wester, Wolfgang Weber
Journal of Nuclear Medicine May 2020, 61 (5) 696-701; DOI: 10.2967/jnumed.119.234914
Jump to section
Related Articles
Cited By...
- Unspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
- Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
- Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
- Utility of 18F-rhPSMA-7.3 PET for Imaging of Primary Prostate Cancer and Preoperative Efficacy in N-Staging of Unfavorable Intermediate- to Very High-Risk Patients Validated by Histopathology
- 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
- Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
- The Influence of Specific Activity on the Biodistribution of 18F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET Data
- Detection Efficacy of 18F-rhPSMA-7.3 PET/CT and Impact on Management in Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Before Potential Salvage Treatment
- Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
- Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor Positivity
- Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
- Positive Predictive Value and Correct Detection Rate of 18F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard
- Safety, Biodistribution, and Radiation Dosimetry of 18F-rhPSMA-7.3 in Healthy Adult Volunteers
- Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer